zolpidem has been researched along with Akinetic Autism in 2 studies
Zolpidem: An imidazopyridine derivative and short-acting GABA-A receptor agonist that is used for the treatment of INSOMNIA.
zolpidem : An imidazo[1,2-a]pyridine compound having a 4-tolyl group at the 2-position, an N,N-dimethylcarbamoylmethyl group at the 3-position and a methyl substituent at the 6-position.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arnts, H | 1 |
| van Erp, WS | 1 |
| Lavrijsen, JCM | 1 |
| van Gaal, S | 1 |
| Groenewegen, HJ | 1 |
| van den Munckhof, P | 1 |
| Schiff, ND | 1 |
| Posner, JB | 1 |
1 review available for zolpidem and Akinetic Autism
| Article | Year |
|---|---|
On the pathophysiology and treatment of akinetic mutism.
Topics: Adrenergic Uptake Inhibitors; Akinetic Mutism; Animals; Dopamine Agonists; Dopamine Uptake Inhibitor | 2020 |
1 other study available for zolpidem and Akinetic Autism
| Article | Year |
|---|---|
Another "Awakenings".
Topics: Akinetic Mutism; Arousal; GABA Agonists; Humans; Pyridines; Zolpidem | 2007 |